510(k) · Cleared
ClearedNitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Blue); Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Black)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Hartalega NGC Sdn. Bhd. · LZA Polymer Patient Examination Glove
Cleared on Jun 17, 2026 as substantially equivalent to K200019 (Hartalega NGC Sdn. Bhd., 2020) after a 92-day review. Its family tree reaches back 1 generation to 2020.
- Decided
- Jun 17, 2026
- Review
- 92 days
- Class
- Class I
- Product code
- LZA
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K200019 (2020). No later device cites it as a predicate yet.
- Root · 1 generation backK200019 Nitrile Powder Free Examination Gloved Tested for Use with…Hartalega NGC Sdn. Bhd. · 2020 · Recalled
- This deviceK260867 Nitrile Powder Free Examination Gloves Tested for Use with…Hartalega NGC Sdn. Bhd. · 2026
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K200019 | Nitrile Powder Free Examination Gloved Tested for Use with Chemotherapy Drugs… | Hartalega NGC Sdn. Bhd. | 2020 | 1 |
| 0 (this device) | K260867 | Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs… | Hartalega NGC Sdn. Bhd. | 2026 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZA device
- #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K200019 | Nitrile Powder Free Examination Gloved Tested for Use with Chemotherapy Drugs and…Summary page 7…: LZA, LZC, QDO, OPJ Regulation Number : 21 CFR 880.6250 PREDICATE DEVICE INFORMATION 510(k) Number : K200019 Manufacturer : Hartalega NGC Sdn. Bhd. Trade Name (Proprietary Name) : Nitrile Powder Free E… | 2020 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has a recall.
- 1 other device also cites its predicate K200019.
How does its category compare?
All LZA devicesLZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.
FDA decisions per year · LZA
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZA
110in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZA
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZA
73in 2025
MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 21 | 95 | 0 | 7 |
| 2008 | 18 | 97 | 0 | 2 |
| 2009 | 28 | 112 | 0 | 12 |
| 2010 | 31 | 97 | 0 | 12 |
| 2011 | 26 | 122 | 0 | 9 |
| 2012 | 33 | 110 | 0 | 11 |
| 2013 | 20 | 130 | 0 | 10 |
| 2014 | 27 | 197 | 0 | 8 |
| 2015 | 20 | 112 | 1 | 12 |
| 2016 | 30 | 171 | 1 | 25 |
| 2017 | 44 | 124 | 0 | 4 |
| 2018 | 22 | 178 | 0 | 3 |
| 2019 | 25 | 212 | 0 | 21 |
| 2020 | 30 | 101 | 0 | 4 |
| 2021 | 139 | 111 | 0 | 20 |
| 2022 | 146 | 111 | 0 | 19 |
| 2023 | 62 | 92 | 0 | 24 |
| 2024 | 30 | 89 | 0 | 76 |
| 2025 | 24 | 110 | 0 | 73 |
| 2026 | 15 | 103 | 3 | — |
What is it indicated for?
Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drug and Fentanyl Citrate (Blue) is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate. The list of Chemotherapy Drugs tested (with breakthrough time) are: Chemotherapy Drug and Concentration Minimum…
Read the full statement (416 words)
Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drug and Fentanyl Citrate (Blue) is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate.
The list of Chemotherapy Drugs tested (with breakthrough time) are:
Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time in Minutes
Carmustine (3.3 mg/ml) 20.0
Cisplatin (1.0 mg/ml) >240
Cyclophosphamide (Cytoxan) (20.0 mg/ml) >240
Dacarbazine (10.0 mg/ml) >240
Doxorubicin Hydrochloride (2.0 mg/ml) >240
Etoposide (Toposar) (20.0 mg/ml) >240
Fluorouracil (50.0 mg/ml) >240
Methotrexate (25.0 mg/ml) >240
Mitomycin C (0.5 mg/ml) >240
Paclitaxel (Taxol) (6.0 mg/ml) >240
Thiotepa (10.0 mg/ml) 54.0
Vincristine Sulfate (1.0 mg/ml) >240
5-Azacytidine (25.0 mg/ml) >240
Carboplatin (10.0 mg/ml) >240
Docetaxel (10 mg/ml) >240
Epirubicin (2.0 mg/mL) >240
Gemcitabine (38 mg/ml) >240
Ifosfamide (50 mg/ml) >240
Irinotecan (20 mg/ml) >240
Mitoxantrone (2.0 mg/ml) >240
Oncovin (1.0 mg/ml) >240
Oxaliplatin (5 mg/ml) >240
Vinorelbine (10 mg/ml) >240
Caution: Testing showed a minimum breakthrough time of 20.0 minutes with Carmustine and 54.0 minutes with Thiotepa.
Warning: Do not use with Carmustine.
Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time in Minutes
Fentanyl Citrate Injection (100 mcg/2ml) >240
Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drug and Fentanyl Citrate (Black) is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs and Fentanyl Citrate.
The list of Chemotherapy Drugs tested (with breakthrough time) are:
Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time in Minutes
Carmustine (3.3 mg/ml) 25.0
Cisplatin (1.0 mg/ml) >240
Cyclophosphamide (Cytoxan) (20.0 mg/ml) >240
Dacarbazine (10.0 mg/ml) >240
Doxorubicin Hydrochloride (2.0 mg/ml) >240
Etoposide (Toposar) (20.0 mg/ml) >240
Fluorouracil (50.0 mg/ml) >240
Methotrexate (25.0 mg/ml) >240
Mitomycin C (0.5 mg/ml) >240
Paclitaxel (Taxol) (6.0 mg/ml) >240
Thiotepa (10.0 mg/ml) 55.7
Vincristine Sulfate (1.0 mg/ml) >240
5-Azacytidine (25.0 mg/ml) >240
Carboplatin (10.0 mg/ml) >240
Docetaxel (10 mg/ml) >240
Epirubicin (2.0 mg/mL) >240
Gemcitabine (38 mg/ml) >240
Ifosfamide (50 mg/ml) >240
Irinotecan (20 mg/ml) >240
Mitoxantrone (2.0 mg/ml) >240
Oncovin (1.0 mg/ml) >240
Oxaliplatin (5 mg/ml) >240
Vinorelbine (10 mg/ml) >240
Caution: Testing showed a minimum breakthrough time of 25.0 minutes with Carmustine and 55.7 minutes with Thiotepa.
Warning: Do not use with Carmustine
Fentanyl Citrate and Concentration Minimum Breakthrough Detection Time in Minutes
Fentanyl Citrate Injection (100 mcg/2ml) >240
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K260867 · printed Nov 5, 2026
Cite this page
510(k) Report. “K260867: Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Blue); Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (Black).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K260867
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded Oct 30, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026